Silgan (SLGN) Financials

$54.50 -0.42 (-0.76%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$54.44 -0.05 (-0.09%)

As of 05/23/2025 07:44 PM Eastern

Annual Income Statements for Silgan

This table shows Silgan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	276	326	341	359	309	194	224	270	153	172
Consolidated Net Income / (Loss)	276	326	341	359	309	194	224	270	153	172
Net Income / (Loss) Continuing Operations	276	326	341	359	309	194	224	270	153	172
Total Pre-Tax Income	348	422	474	466	407	252	293	240	232	253
Total Operating Income	515	595	602	576	512	359	412	357	300	320
Total Gross Profit	1,012	993	1,048	918	867	714	690	635	512	554
Total Revenue	5,855	5,988	6,411	5,677	4,922	4,490	4,449	4,090	3,613	3,764
Operating Revenue	5,855	5,988	6,411	5,677	4,922	4,490	4,449	4,090	3,613	3,764
Total Cost of Revenue	4,843	4,996	5,364	4,759	4,055	3,776	3,759	3,455	3,101	3,210
Operating Cost of Revenue	4,843	4,996	5,364	4,759	4,055	3,776	3,759	3,455	3,101	3,210
Total Operating Expenses	497	397	446	342	355	354	278	278	212	234
Selling, General & Admin Expense	438	384	417	378	378	316	308	305	220	220
Restructuring Charge	59	8.41	74	15	16	56	6.25	5.83	19	14
Other Special Charges / (Income)	-1.19	4.33	-45	-51	-39	-18	-37	-33	-27	-
Total Other Income / (Expense), net	-167	-173	-128	-110	-105	-107	-119	-117	-68	-67
Interest Expense	167	173	128	110	105	107	119	117	68	67
Income Tax Expense	72	96	133	107	98	58	69	-30	79	80
Other Gains / (Losses), net	0.69	0.00	0.00	-	-	-	-	-	-	-
Basic Earnings per Share	$2.59	$3.00	$3.09	$3.25	$2.79	$1.75	$2.03	$2.44	$1.28	$1.41
Weighted Average Basic Shares Outstanding	106.79M	106.50M	110.08M	110.41M	110.06M	110.78M	110.60M	110.35M	119.73M	61.02M
Diluted Earnings per Share	$2.58	$2.98	$3.07	$3.23	$2.77	$1.74	$2.01	$2.42	$1.27	$1.41
Weighted Average Diluted Shares Outstanding	106.79M	106.50M	110.08M	110.41M	110.06M	110.78M	110.60M	110.35M	119.73M	61.02M
Weighted Average Basic & Diluted Shares Outstanding	106.79M	106.50M	110.08M	110.41M	110.06M	110.78M	110.60M	110.35M	119.73M	61.02M
Cash Dividends to Common per Share	$0.76	$0.72	$0.64	$0.56	$0.48	$0.44	$0.40	$0.36	$0.68	$0.32

This table shows Silgan's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	68	45	100	76	55	64	111	79	72	25	139
Consolidated Net Income / (Loss)	68	45	100	76	55	64	111	79	72	25	139
Net Income / (Loss) Continuing Operations	68	45	100	76	55	64	111	79	72	25	139
Total Pre-Tax Income	88	49	125	101	73	84	147	97	94	47	186
Total Operating Income	131	94	167	142	112	126	194	144	131	81	219
Total Gross Profit	270	239	293	256	223	219	286	250	238	233	308
Total Revenue	1,467	1,411	1,745	1,381	1,317	1,340	1,803	1,427	1,418	1,455	1,970
Operating Revenue	1,467	1,411	1,745	1,381	1,317	1,340	1,803	1,427	1,418	1,455	1,970
Total Cost of Revenue	1,196	1,172	1,452	1,125	1,094	1,122	1,517	1,177	1,180	1,223	1,663
Operating Cost of Revenue	1,196	1,172	1,452	1,125	1,094	1,122	1,517	1,177	1,180	1,223	1,663
Total Operating Expenses	140	145	126	114	112	92	92	106	107	152	88
Selling, General & Admin Expense	129	124	106	108	100	97	84	102	101	96	97
Restructuring Charge	11	21	19	6.86	12	-4.80	6.42	2.67	4.12	67	2.73
Other Special Charges / (Income)	-0.19	-0.49	0.12	-0.41	-0.41	0.67	1.08	1.30	1.29	-12	-11
Total Other Income / (Expense), net	-43	-46	-42	-41	-39	-42	-47	-47	-37	-35	-34
Interest Expense	43	46	42	41	39	42	47	47	37	35	34
Income Tax Expense	21	4.29	25	24	18	19	36	18	22	22	47
Other Gains / (Losses), net	1.16	-	-	-	-	-	-	-	-	-	-
Basic Earnings per Share	$0.64	$0.42	$0.94	$0.71	$0.52	$0.61	$1.02	$0.72	$0.65	$0.22	$1.26
Weighted Average Basic Shares Outstanding	106.92M	106.79M	106.85M	106.84M	106.65M	106.50M	108.42M	110.13M	110.22M	110.08M	110.28M
Diluted Earnings per Share	$0.63	$0.42	$0.93	$0.71	$0.52	$0.60	$1.02	$0.71	$0.65	$0.23	$1.25
Weighted Average Diluted Shares Outstanding	107.34M	106.79M	107.14M	107.02M	107.05M	106.50M	108.75M	110.45M	110.85M	110.08M	110.74M
Weighted Average Basic & Diluted Shares Outstanding	106.99M	106.79M	106.79M	106.78M	106.78M	106.50M	106.50M	109.95M	110.25M	110.08M	110.08M
Cash Dividends to Common per Share	$0.20	-	$0.19	$0.19	$0.19	-	$0.18	$0.18	$0.18	-	$0.16

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	180	57	-46	222	206	131	19	29	-75	-123
Net Cash From Operating Activities	722	483	748	557	603	507	507	390	395	336
Net Cash From Continuing Operating Activities	722	483	748	557	603	507	507	390	395	336
Net Income / (Loss) Continuing Operations	276	326	341	359	309	194	224	270	153	172
Consolidated Net Income / (Loss)	276	326	341	359	309	194	224	270	153	172
Depreciation Expense	276	263	263	250	219	206	192	174	143	142
Amortization Expense	5.47	5.37	5.46	5.57	4.54	3.46	3.77	4.26	4.14	4.16
Non-Cash Adjustments To Reconcile Net Income	76	24	92	97	36	75	24	28	32	26
Changes in Operating Assets and Liabilities, net	88	-136	47	-155	34	28	63	-86	62	-9.48
Net Cash From Investing Activities	-1,176	-224	-216	-976	-1,163	-230	-190	-1,198	-180	-237
Net Cash From Continuing Investing Activities	-1,176	-224	-216	-976	-1,163	-230	-190	-1,198	-180	-237
Purchase of Property, Plant & Equipment	-263	-227	-216	-232	-224	-231	-191	-174	-192	-237
Acquisitions	-922	0.00	-2.50	-746	-941	0.00	0.00	-1,024	0.00	-0.69
Sale of Property, Plant & Equipment	7.80	1.76	3.35	2.80	-	-	-	-	-	0.90
Other Investing Activities, net	0.26	1.24	-0.69	-0.82	1.87	0.85	1.05	0.60	12	-
Net Cash From Financing Activities	663	-211	-570	649	760	-146	-294	837	-289	-221
Net Cash From Continuing Financing Activities	663	-211	-570	649	760	-146	-294	837	-289	-221
Repayment of Debt	-1,120	-1,179	-1,120	-2,106	-1,831	-462	-1,280	-2,089	-865	-767
Repurchase of Common Equity	-9.32	-184	-45	-8.57	-42	-28	-7.83	-4.12	-281	-173
Payment of Dividends	-82	-79	-72	-62	-54	-51	-45	-40	-41	-40
Issuance of Debt	1,977	1,134	835	2,685	2,681	400	1,043	2,961	919	740
Other Financing Activities, net	-103	96	-167	140	5.20	-4.66	-4.13	8.85	-23	19
Effect of Exchange Rate Changes	-28	9.91	-9.03	-7.53	6.47	-0.74	-3.70	0.00	0.00	-
Cash Interest Paid	160	155	124	102	90	109	118	98	65	64
Cash Income Taxes Paid	92	116	94	94	121	41	47	70	58	50

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-470	454	66	-5.85	-334	336	71	-264	-85	342	-4.23
Net Cash From Operating Activities	-683	936	313	21	-548	1,079	216	-180	-632	866	234
Net Cash From Continuing Operating Activities	-683	936	313	21	-548	1,079	216	-180	-632	866	234
Net Income / (Loss) Continuing Operations	68	45	100	76	55	64	111	79	72	25	139
Consolidated Net Income / (Loss)	68	45	100	76	55	64	111	79	72	25	139
Depreciation Expense	79	77	67	66	66	67	65	67	65	61	65
Amortization Expense	1.41	1.43	1.35	1.35	1.35	1.34	1.35	1.34	1.33	-	-
Non-Cash Adjustments To Reconcile Net Income	15	26	23	11	16	-0.58	11	6.14	7.80	70	6.77
Changes in Operating Assets and Liabilities, net	-847	786	122	-133	-687	947	28	-333	-778	705	24
Net Cash From Investing Activities	-82	-987	-61	-56	-72	-53	-54	-50	-67	-54	-41
Net Cash From Continuing Investing Activities	-82	-987	-61	-56	-72	-53	-54	-50	-67	-54	-41
Purchase of Property, Plant & Equipment	-83	-71	-61	-56	-75	-53	-55	-50	-68	-53	-44
Sale of Property, Plant & Equipment	0.05	4.58	0.24	0.49	2.50	0.13	0.95	0.30	0.37	-	-
Other Investing Activities, net	0.40	0.55	-0.34	-0.25	0.30	-0.03	0.70	0.06	0.51	-2.68	2.68
Net Cash From Financing Activities	283	528	-195	36	293	-699	-86	-36	610	-479	-187
Net Cash From Continuing Financing Activities	283	528	-195	36	293	-699	-86	-36	610	-479	-187
Repayment of Debt	-712	-709	-235	-60	-115	-845	-39	-216	-79	-529	-236
Repurchase of Common Equity	-6.87	-1.58	-	-0.06	-7.68	-0.05	-153	-18	-13	-5.72	-
Payment of Dividends	-22	-20	-20	-20	-21	-19	-19	-20	-21	-18	-18
Issuance of Debt	1,111	1,174	63	142	598	5.79	125	218	786	15	66
Other Financing Activities, net	-86	85	-2.01	-25	-161	160	-0.69	-0.86	-62	59	-
Effect of Exchange Rate Changes	13	-23	-	-	-6.69	9.41	-5.18	1.86	3.83	9.11	-9.96
Cash Interest Paid	51	27	43	41	50	31	43	46	35	33	32
Cash Income Taxes Paid	12	22	26	27	17	20	11	65	20	27	38

This table presents Silgan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	8,585	7,611	7,346	7,771	6,512	4,931	4,579	4,645	3,149	3,193
Total Current Assets	2,523	2,349	2,133	2,296	1,799	1,407	1,290	1,292	962	1,045
Cash & Equivalents	823	643	586	631	409	204	73	54	25	100
Accounts Receivable	594	600	658	711	620	505	511	455	288	281
Inventories, net	928	941	769	799	678	633	635	721	603	628
Prepaid Expenses	177	166	120	154	93	65	71	62	46	36
Plant, Property, & Equipment, net	2,283	1,962	1,931	1,994	0.00	0.00	1,518	1,490	1,157	1,125
Total Noncurrent Assets	3,779	3,301	3,282	3,481	4,712	3,524	1,772	1,864	1,030	1,022
Goodwill	2,316	2,018	1,985	2,038	1,741	1,142	1,148	1,171	605	613
Intangible Assets	869	721	764	831	637	355	383	417	181	195
Other Noncurrent Operating Assets	594	561	533	612	2,334	2,027	240	275	245	214
Total Liabilities & Shareholders' Equity	8,585	7,611	7,346	7,771	6,512	4,931	4,579	4,645	3,149	3,193
Total Liabilities	6,595	5,722	5,628	6,208	5,259	3,908	3,698	3,879	2,680	2,553
Total Current Liabilities	2,248	2,312	1,438	1,509	1,192	1,019	1,079	958	862	781
Short-Term Debt	717	880	80	20	28	30	170	109	217	152
Accounts Payable	1,112	1,076	974	1,133	803	727	713	660	505	477
Accrued Expenses	310	258	285	246	231	195	127	124	94	107
Current Employee Benefit Liabilities	109	98	99	109	130	67	69	66	46	45
Total Noncurrent Liabilities	4,348	3,410	4,190	4,700	4,067	2,889	2,619	2,921	1,818	1,772
Long-Term Debt	3,420	2,546	3,345	3,773	3,223	2,215	2,134	2,439	1,344	1,361
Noncurrent Deferred & Payable Income Tax Liabilities	506	434	389	435	356	255	268	262	298	-
Other Noncurrent Operating Liabilities	422	430	456	491	488	420	217	220	175	411
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Total Equity & Noncontrolling Interests	1,990	1,889	1,718	1,563	1,253	1,023	881	766	469	639
Total Preferred & Common Equity	1,990	1,889	1,718	1,563	1,253	1,023	881	766	469	639
Total Common Equity	1,990	1,889	1,718	1,563	1,253	1,023	881	766	469	639
Common Stock	370	356	342	327	308	291	278	264	251	238
Retained Earnings	3,403	3,208	2,961	2,692	2,395	2,141	1,998	1,810	1,559	1,446
Treasury Stock	-1,429	-	-1,239	-1,196	-1,190	-1,149	-1,126	-1,119	-1,116	-836
Accumulated Other Comprehensive Income / (Loss)	-353	-251	-345	-260	-261	-260	-269	-189	-224	-209

This table presents Silgan's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	8,768	7,747	7,693	7,574	7,812	7,914	7,862	7,519
Total Current Assets	2,597	2,519	2,539	2,376	2,662	2,698	2,625	2,332
Cash & Equivalents	353	369	303	309	307	237	501	244
Accounts Receivable	1,013	1,210	1,057	946	1,296	1,068	936	1,124
Inventories, net	1,055	780	1,006	957	919	1,252	1,055	851
Prepaid Expenses	176	160	173	164	140	143	133	113
Plant, Property, & Equipment, net	2,303	1,956	1,934	1,944	1,912	1,934	1,930	1,887
Total Noncurrent Assets	3,868	3,272	3,221	3,254	3,239	3,281	3,307	3,301
Goodwill	2,373	2,024	1,987	1,997	1,980	2,007	2,002	1,915
Intangible Assets	890	681	685	702	724	745	756	758
Other Noncurrent Operating Assets	605	566	549	555	535	528	549	628
Total Liabilities & Shareholders' Equity	8,768	7,747	7,693	7,574	7,812	7,914	7,862	7,519
Total Liabilities	6,685	5,693	5,760	5,674	6,030	6,043	6,080	5,826
Total Current Liabilities	2,285	2,306	2,396	2,289	1,916	1,880	1,844	1,681
Short-Term Debt	1,145	1,254	1,398	1,346	898	811	785	591
Accounts Payable	737	679	658	610	652	752	716	688
Accrued Expenses	284	266	239	234	269	222	241	291
Current Employee Benefit Liabilities	119	106	101	100	96	95	102	110
Total Noncurrent Liabilities	4,399	3,388	3,364	3,385	4,115	4,163	4,236	4,145
Long-Term Debt	3,483	2,554	2,531	2,535	3,313	3,351	3,370	3,247
Noncurrent Deferred & Payable Income Tax Liabilities	487	421	425	432	380	384	389	425
Other Noncurrent Operating Liabilities	429	413	408	418	422	427	477	473
Total Equity & Noncontrolling Interests	2,083	2,054	1,934	1,900	1,782	1,871	1,781	1,693
Total Preferred & Common Equity	2,083	2,054	1,934	1,900	1,782	1,871	1,781	1,693
Total Common Equity	2,083	2,054	1,934	1,900	1,782	1,871	1,781	1,693
Common Stock	373	366	362	358	351	347	344	338
Retained Earnings	3,449	3,378	3,299	3,243	3,163	3,072	3,013	2,954
Accumulated Other Comprehensive Income / (Loss)	-303	-261	-298	-272	-310	-280	-325	-365
Other Equity Adjustments	-1,435	-1,429	-1,429	-1,429	-1,423	-1,269	-1,251	-1,233

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.23%	-6.60%	12.94%	15.34%	9.62%	0.92%	8.78%	13.20%	-4.01%	-3.78%
EBITDA Growth	-7.82%	-0.71%	4.59%	13.04%	29.26%	-6.28%	13.51%	19.78%	-4.13%	-9.16%
EBIT Growth	-13.49%	-1.08%	4.49%	12.44%	42.53%	-12.77%	15.44%	19.10%	-6.28%	-11.37%
NOPAT Growth	-11.17%	6.25%	-2.46%	14.17%	40.62%	-12.20%	-21.64%	102.65%	-9.10%	-5.73%
Net Income Growth	-15.21%	-4.37%	-5.08%	16.31%	59.29%	-13.47%	-16.93%	75.84%	-11.06%	-5.47%
EPS Growth	-13.42%	-2.93%	-4.95%	16.61%	59.20%	-13.43%	-16.94%	90.55%	-9.93%	-50.70%
Operating Cash Flow Growth	49.58%	-35.52%	34.40%	-7.58%	18.75%	0.16%	29.96%	-1.21%	17.51%	-3.58%
Free Cash Flow Firm Growth	-164.39%	-42.47%	421.82%	71.01%	-297.29%	-29.47%	154.17%	-448.17%	3.37%	-43.25%
Invested Capital Growth	13.49%	2.53%	-3.52%	15.38%	33.64%	-1.58%	-4.50%	62.48%	-2.26%	-0.90%
Revenue Q/Q Growth	1.23%	-1.89%	0.25%	3.89%	3.76%	-0.49%	1.71%	4.87%	-0.65%	-2.10%
EBITDA Q/Q Growth	-2.58%	6.93%	-4.98%	4.79%	6.36%	0.31%	-0.68%	10.31%	0.95%	-0.83%
EBIT Q/Q Growth	-5.83%	8.17%	-7.32%	4.29%	7.00%	-1.61%	-2.16%	10.60%	-0.10%	-2.02%
NOPAT Q/Q Growth	-3.39%	12.41%	-12.46%	6.92%	7.90%	-2.67%	-32.45%	84.55%	-1.55%	1.73%
Net Income Q/Q Growth	-6.55%	13.92%	-15.06%	7.46%	8.91%	-1.70%	-32.52%	83.15%	-1.83%	1.72%
EPS Q/Q Growth	-6.52%	14.18%	-14.72%	7.31%	9.06%	-1.69%	-32.55%	120.00%	323.33%	-48.91%
Operating Cash Flow Q/Q Growth	-16.52%	78.81%	68.15%	16.43%	-4.09%	3.33%	24.36%	-2.96%	6.15%	-4.96%
Free Cash Flow Firm Q/Q Growth	-136.11%	2,913.15%	15.50%	56.11%	-5.23%	-26.30%	37.43%	-1.91%	42.77%	-36.06%
Invested Capital Q/Q Growth	-3.46%	-17.80%	-13.80%	-11.06%	-8.46%	-12.52%	-14.95%	-7.66%	-18.99%	-16.10%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	17.28%	16.58%	16.34%	16.18%	17.62%	15.90%	15.50%	15.52%	14.17%	14.72%
EBITDA Margin	13.60%	14.43%	13.57%	14.66%	14.95%	12.68%	13.66%	13.09%	12.37%	12.38%
Operating Margin	8.80%	9.94%	9.39%	10.15%	10.41%	8.01%	9.26%	8.73%	8.30%	8.50%
EBIT Margin	8.80%	9.94%	9.39%	10.15%	10.41%	8.01%	9.26%	8.73%	8.30%	8.50%
Profit (Net Income) Margin	4.72%	5.44%	5.32%	6.33%	6.27%	4.32%	5.03%	6.59%	4.24%	4.58%
Tax Burden Percent	79.49%	77.22%	71.89%	77.00%	75.84%	76.87%	76.37%	112.51%	66.12%	68.18%
Interest Burden Percent	67.50%	70.89%	78.77%	80.94%	79.45%	70.14%	71.17%	67.14%	77.38%	79.07%
Effective Tax Rate	20.70%	22.78%	28.11%	23.00%	24.16%	23.13%	23.63%	-12.51%	33.88%	31.82%
Return on Invested Capital (ROIC)	8.19%	9.96%	9.32%	10.06%	10.86%	8.95%	9.88%	15.25%	9.77%	10.57%
ROIC Less NNEP Spread (ROIC-NNEP)	3.86%	5.20%	6.26%	7.24%	7.59%	5.08%	6.04%	8.70%	6.73%	7.29%
Return on Net Nonoperating Assets (RNNOA)	6.06%	8.11%	11.45%	15.45%	16.27%	11.41%	17.32%	28.40%	17.90%	14.99%
Return on Equity (ROE)	14.25%	18.07%	20.78%	25.51%	27.13%	20.35%	27.19%	43.65%	27.67%	25.56%
Cash Return on Invested Capital (CROIC)	-4.45%	7.47%	12.91%	-4.22%	-17.94%	10.54%	14.48%	-32.35%	12.06%	11.48%
Operating Return on Assets (OROA)	6.36%	7.96%	7.96%	8.07%	8.96%	7.56%	8.93%	9.16%	9.45%	9.89%
Return on Assets (ROA)	3.41%	4.36%	4.51%	5.03%	5.40%	4.08%	4.86%	6.92%	4.84%	5.33%
Return on Common Equity (ROCE)	14.25%	18.07%	20.78%	25.51%	27.13%	20.35%	27.19%	43.65%	27.67%	25.56%
Return on Equity Simple (ROE_SIMPLE)	13.89%	17.25%	19.84%	22.98%	24.64%	18.94%	25.42%	35.20%	32.67%	26.97%
Net Operating Profit after Tax (NOPAT)	408	460	433	444	389	276	315	402	198	218
NOPAT Margin	6.98%	7.68%	6.75%	7.81%	7.90%	6.15%	7.07%	9.82%	5.49%	5.79%
Net Nonoperating Expense Percent (NNEP)	4.33%	4.76%	3.06%	2.82%	3.27%	3.86%	3.84%	6.55%	3.04%	3.29%
Return On Investment Capital (ROIC_SIMPLE)	6.67%	8.65%	8.41%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	82.72%	83.42%	83.66%	83.82%	82.38%	84.10%	84.50%	84.48%	85.83%	85.28%
SG&A Expenses to Revenue	7.49%	6.42%	6.50%	6.66%	7.67%	7.03%	6.93%	7.46%	6.09%	5.84%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.48%	6.63%	6.95%	6.03%	7.21%	7.89%	6.24%	6.79%	5.87%	6.23%
Earnings before Interest and Taxes (EBIT)	515	595	602	576	512	359	412	357	300	320
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	796	864	870	832	736	569	608	535	447	466
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.79	2.51	3.22	2.91	3.11	3.15	2.74	3.85	2.96	2.25
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.95	0.79	0.86	0.80	0.79	0.72	0.54	0.72	0.38	0.38
Price to Earnings (P/E)	20.11	14.56	16.23	12.68	12.62	16.64	10.76	10.94	9.06	8.35
Dividend Yield	1.46%	1.62%	1.27%	1.36%	1.36%	1.51%	1.84%	1.68%	2.95%	2.68%
Earnings Yield	4.97%	6.87%	6.16%	7.88%	7.92%	6.01%	9.29%	9.14%	11.04%	11.98%
Enterprise Value to Invested Capital (EV/IC)	1.67	1.61	1.84	1.63	1.65	1.72	1.49	1.67	1.46	1.39
Enterprise Value to Revenue (EV/Rev)	1.52	1.26	1.31	1.36	1.37	1.17	1.04	1.33	0.81	0.76
Enterprise Value to EBITDA (EV/EBITDA)	11.14	8.71	9.62	9.27	9.16	9.25	7.64	10.17	6.55	6.12
Enterprise Value to EBIT (EV/EBIT)	17.23	12.65	13.91	13.39	13.15	14.65	11.27	15.25	9.76	8.92
Enterprise Value to NOPAT (EV/NOPAT)	21.72	16.38	19.35	17.39	17.34	19.05	14.75	13.55	14.76	13.09
Enterprise Value to Operating Cash Flow (EV/OCF)	12.29	15.60	11.19	13.86	11.18	10.38	9.17	13.97	7.42	8.50
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	21.85	13.97	0.00	0.00	16.18	10.06	0.00	11.96	12.06
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.08	1.81	1.99	2.43	2.60	2.19	2.62	3.33	3.33	2.37
Long-Term Debt to Equity	1.72	1.35	1.95	2.41	2.57	2.16	2.42	3.18	2.86	2.13
Financial Leverage	1.57	1.56	1.83	2.13	2.15	2.24	2.87	3.26	2.66	2.06
Leverage Ratio	4.18	4.15	4.61	5.07	5.03	4.99	5.60	6.31	5.72	4.79
Compound Leverage Factor	2.82	2.94	3.63	4.11	3.99	3.50	3.99	4.24	4.43	3.79
Debt to Total Capital	67.52%	64.46%	66.59%	70.82%	72.18%	68.68%	72.34%	76.88%	76.89%	70.31%
Short-Term Debt to Total Capital	11.70%	16.56%	1.56%	0.38%	0.62%	0.91%	5.34%	3.28%	10.69%	7.08%
Long-Term Debt to Total Capital	55.82%	47.90%	65.04%	70.44%	71.56%	67.77%	67.00%	73.60%	66.20%	63.23%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	32.48%	35.54%	33.41%	29.18%	27.82%	31.32%	27.66%	23.12%	23.11%	29.69%
Debt to EBITDA	5.19	3.97	3.94	4.56	4.42	3.94	3.79	4.76	3.49	3.25
Net Debt to EBITDA	4.16	3.22	3.26	3.80	3.86	3.58	3.67	4.66	3.44	3.03
Long-Term Debt to EBITDA	4.29	2.95	3.84	4.53	4.38	3.89	3.51	4.56	3.01	2.92
Debt to NOPAT	10.13	7.45	7.92	8.55	8.37	8.12	7.32	6.34	7.88	6.94
Net Debt to NOPAT	8.11	6.05	6.56	7.13	7.31	7.38	7.09	6.21	7.75	6.48
Long-Term Debt to NOPAT	8.37	5.54	7.73	8.50	8.29	8.01	6.78	6.07	6.78	6.24
Altman Z-Score	1.98	2.14	2.41	2.02	2.09	2.35	2.33	2.22	2.50	2.58
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.12	1.02	1.48	1.52	1.51	1.38	1.20	1.35	1.12	1.34
Quick Ratio	0.63	0.54	0.86	0.89	0.86	0.70	0.54	0.53	0.36	0.49
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-222	345	599	-186	-642	325	461	-852	245	237
Operating Cash Flow to CapEx	283.10%	214.43%	352.34%	242.67%	268.76%	219.69%	265.23%	223.45%	205.61%	142.03%
Free Cash Flow to Firm to Interest Expense	-1.33	1.99	4.69	-1.70	-6.10	3.03	3.88	-7.26	3.61	3.54
Operating Cash Flow to Interest Expense	4.31	2.78	5.86	5.07	5.72	4.73	4.26	3.32	5.82	5.02
Operating Cash Flow Less CapEx to Interest Expense	2.79	1.49	4.19	2.98	3.59	2.57	2.66	1.84	2.99	1.48
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.72	0.80	0.85	0.80	0.86	0.94	0.96	1.05	1.14	1.16
Accounts Receivable Turnover	9.81	9.52	9.36	8.53	8.75	8.84	9.21	11.01	12.69	12.72
Inventory Turnover	5.18	5.84	6.84	6.45	6.19	5.96	5.54	5.22	5.04	5.45
Fixed Asset Turnover	2.76	3.08	3.27	0.00	0.00	0.00	2.96	3.09	3.17	3.44
Accounts Payable Turnover	4.43	4.87	5.09	4.92	5.30	5.25	5.48	5.93	6.32	7.12
Days Sales Outstanding (DSO)	37.21	38.32	38.98	42.78	41.70	41.31	39.63	33.15	28.75	28.69
Days Inventory Outstanding (DIO)	70.43	62.48	53.36	56.62	58.99	61.27	65.84	69.94	72.45	66.91
Days Payable Outstanding (DPO)	82.43	74.89	71.70	74.24	68.85	69.58	66.63	61.50	57.79	51.23
Cash Conversion Cycle (CCC)	25.20	25.91	20.63	25.16	31.84	33.00	38.84	41.59	43.42	44.38
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,304	4,673	4,558	4,724	4,095	3,064	3,113	3,260	2,006	2,053
Invested Capital Turnover	1.17	1.30	1.38	1.29	1.38	1.45	1.40	1.55	1.78	1.83
Increase / (Decrease) in Invested Capital	630	115	-166	630	1,031	-49	-147	1,254	-46	-19
Enterprise Value (EV)	8,873	7,530	8,372	7,716	6,739	5,265	4,643	5,443	2,926	2,853
Market Capitalization	5,559	4,746	5,532	4,555	3,897	3,224	2,411	2,950	1,389	1,440
Book Value per Share	$18.63	$17.74	$15.61	$14.15	$11.33	$9.24	$7.97	$6.94	$7.78	$10.58
Tangible Book Value per Share	($11.20)	($7.98)	($9.36)	($11.83)	($10.18)	($4.27)	($5.88)	($7.45)	($5.24)	($2.79)
Total Capital	6,126	5,316	5,144	5,356	4,504	3,268	3,186	3,313	2,031	2,153
Total Debt	4,137	3,427	3,425	3,793	3,251	2,244	2,305	2,547	1,562	1,514
Total Long-Term Debt	3,420	2,546	3,345	3,773	3,223	2,215	2,134	2,439	1,344	1,361
Net Debt	3,314	2,784	2,840	3,162	2,842	2,041	2,232	2,494	1,537	1,414
Capital Expenditures (CapEx)	255	225	212	229	224	231	191	174	192	236
Debt-free, Cash-free Net Working Capital (DFCFNWC)	169	275	189	176	226	214	308	389	293	316
Debt-free Net Working Capital (DFNWC)	992	917	775	808	636	418	381	442	317	416
Net Working Capital (NWC)	275	37	695	787	608	388	211	334	100	264
Net Nonoperating Expense (NNE)	132	134	92	85	80	83	91	132	45	46
Net Nonoperating Obligations (NNO)	3,314	2,784	2,840	3,162	2,842	2,041	2,232	2,494	1,537	1,414
Total Depreciation and Amortization (D&A)	281	269	268	256	224	210	196	178	147	146
Debt-free, Cash-free Net Working Capital to Revenue	2.89%	4.58%	2.95%	3.10%	4.59%	4.77%	6.93%	9.51%	8.10%	8.41%
Debt-free Net Working Capital to Revenue	16.95%	15.32%	12.09%	14.23%	12.91%	9.31%	8.57%	10.82%	8.79%	11.06%
Net Working Capital to Revenue	4.70%	0.62%	10.84%	13.87%	12.34%	8.65%	4.74%	8.16%	2.78%	7.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.59	$3.00	$3.09	$3.25	$2.79	$1.75	$2.03	$2.44	$2.56	$2.83
Adjusted Weighted Average Basic Shares Outstanding	106.79M	106.50M	110.08M	110.41M	110.06M	110.78M	110.43M	110.39M	55.05M	60.39M
Adjusted Diluted Earnings per Share	$2.58	$2.98	$3.07	$3.23	$2.77	$1.74	$2.01	$2.42	$2.55	$2.81
Adjusted Weighted Average Diluted Shares Outstanding	106.79M	106.50M	110.08M	110.41M	110.06M	110.78M	110.43M	110.39M	55.05M	60.39M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	106.79M	106.50M	110.08M	110.41M	110.06M	110.78M	110.43M	110.39M	55.05M	60.39M
Normalized Net Operating Profit after Tax (NOPAT)	455	470	453	416	371	306	291	231	193	228
Normalized NOPAT Margin	7.77%	7.84%	7.07%	7.33%	7.55%	6.81%	6.55%	5.64%	5.34%	6.05%
Pre Tax Income Margin	5.94%	7.05%	7.40%	8.21%	8.27%	5.62%	6.59%	5.86%	6.42%	6.72%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.08	3.44	4.71	5.25	4.87	3.35	3.47	3.04	4.42	4.78
NOPAT to Interest Expense	2.44	2.65	3.39	4.04	3.69	2.57	2.65	3.42	2.92	3.26
EBIT Less CapEx to Interest Expense	1.55	2.14	3.05	3.16	2.74	1.20	1.86	1.56	1.59	1.25
NOPAT Less CapEx to Interest Expense	0.92	1.35	1.72	1.95	1.56	0.42	1.04	1.94	0.09	-0.27
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	29.69%	24.20%	21.11%	17.40%	17.38%	26.23%	19.89%	15.02%	26.66%	23.05%
Augmented Payout Ratio	33.06%	80.65%	34.35%	19.79%	31.02%	40.47%	23.38%	16.55%	209.72%	123.40%

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	11.36%	5.30%	-3.22%	-3.18%	-7.14%	-7.92%	-8.49%	-7.58%	-1.64%	1.12%	19.34%
EBITDA Growth	17.73%	-10.86%	-9.73%	-1.53%	-9.07%	36.58%	-8.37%	-6.11%	-7.09%	-26.45%	22.91%
EBIT Growth	16.85%	-25.28%	-13.81%	-1.49%	-14.87%	55.43%	-11.54%	-8.88%	-8.48%	-36.95%	30.67%
NOPAT Growth	18.01%	-11.57%	-8.73%	-8.10%	-15.71%	126.65%	-10.79%	3.23%	-7.45%	-60.96%	29.38%
Net Income Growth	23.20%	-30.06%	-9.55%	-3.54%	-23.41%	161.96%	-20.25%	-14.87%	-15.14%	-71.08%	30.49%
EPS Growth	21.15%	-30.00%	-8.82%	0.00%	-20.00%	160.87%	-18.40%	-14.46%	-14.47%	-69.74%	30.21%
Operating Cash Flow Growth	-24.75%	-13.25%	45.12%	111.61%	13.29%	24.56%	-7.98%	-112.90%	-136.26%	53.91%	15.17%
Free Cash Flow Firm Growth	-1,736.09%	-2,931.56%	229.36%	259.23%	71.14%	-108.58%	-233.55%	69.50%	103.47%	140.24%	126.42%
Invested Capital Growth	16.22%	13.49%	-3.37%	-4.09%	0.67%	2.53%	7.52%	6.10%	1.34%	-3.52%	-0.46%
Revenue Q/Q Growth	3.93%	-19.14%	26.33%	4.88%	-1.72%	-25.68%	26.38%	0.60%	-2.55%	-26.14%	27.64%
EBITDA Q/Q Growth	22.22%	-26.53%	12.77%	16.27%	-4.83%	-25.60%	23.01%	7.36%	39.00%	-50.09%	26.04%
EBIT Q/Q Growth	38.53%	-43.67%	17.93%	26.97%	-11.42%	-35.02%	34.79%	9.73%	61.72%	-63.02%	38.85%
NOPAT Q/Q Growth	15.83%	-35.62%	24.26%	27.34%	-13.20%	-33.55%	25.12%	16.79%	133.41%	-73.85%	44.79%
Net Income Q/Q Growth	50.81%	-54.96%	31.48%	37.95%	-14.38%	-41.75%	40.22%	9.53%	192.86%	-82.27%	49.67%
EPS Q/Q Growth	50.00%	-54.84%	30.99%	36.54%	-13.33%	-41.18%	43.66%	9.23%	182.61%	-81.60%	50.60%
Operating Cash Flow Q/Q Growth	-173.03%	198.94%	1,397.94%	103.81%	-150.79%	400.05%	219.85%	71.51%	-172.96%	269.40%	377.30%
Free Cash Flow Firm Q/Q Growth	-44.69%	-267.42%	-5.64%	615.74%	368.11%	92.86%	-16.15%	-869.30%	-86.55%	11.16%	126.53%
Invested Capital Q/Q Growth	19.90%	-3.46%	-1.19%	1.61%	17.08%	-17.80%	-1.93%	6.66%	19.25%	-13.80%	-3.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	18.44%	16.94%	16.81%	18.53%	16.97%	16.31%	15.86%	17.53%	16.78%	15.99%	15.62%
EBITDA Margin	14.41%	12.25%	13.49%	15.11%	13.63%	14.47%	14.46%	14.85%	13.92%	9.76%	14.44%
Operating Margin	8.90%	6.68%	9.59%	10.27%	8.48%	9.41%	10.76%	10.09%	9.25%	5.58%	11.14%
EBIT Margin	8.90%	6.68%	9.59%	10.27%	8.48%	9.41%	10.76%	10.09%	9.25%	5.58%	11.14%
Profit (Net Income) Margin	4.63%	3.19%	5.73%	5.51%	4.19%	4.81%	6.13%	5.53%	5.08%	1.69%	7.04%
Tax Burden Percent	77.57%	92.59%	79.78%	75.71%	75.49%	77.04%	75.34%	81.16%	76.25%	52.83%	74.71%
Interest Burden Percent	67.12%	51.65%	74.97%	70.86%	65.41%	66.31%	75.65%	67.50%	71.98%	57.37%	84.62%
Effective Tax Rate	23.76%	8.82%	20.22%	24.29%	24.51%	22.96%	24.66%	18.84%	23.75%	47.17%	25.29%
Return on Invested Capital (ROIC)	6.89%	7.15%	7.91%	8.00%	6.91%	9.41%	9.02%	9.12%	8.35%	4.07%	10.04%
ROIC Less NNEP Spread (ROIC-NNEP)	6.08%	5.81%	7.00%	7.17%	6.11%	8.24%	8.07%	8.14%	7.59%	3.46%	9.36%
Return on Net Nonoperating Assets (RNNOA)	11.99%	9.13%	13.41%	14.23%	11.98%	12.85%	17.42%	18.09%	16.37%	6.33%	22.14%
Return on Equity (ROE)	18.87%	16.27%	21.32%	22.23%	18.90%	22.26%	26.44%	27.21%	24.72%	10.40%	32.18%
Cash Return on Invested Capital (CROIC)	-7.84%	-4.45%	10.99%	11.84%	7.48%	7.47%	0.21%	1.66%	6.52%	12.91%	9.79%
Operating Return on Assets (OROA)	6.54%	4.83%	7.13%	7.69%	6.47%	7.54%	8.57%	8.02%	7.59%	4.73%	9.45%
Return on Assets (ROA)	3.41%	2.31%	4.26%	4.12%	3.19%	3.85%	4.88%	4.39%	4.17%	1.43%	5.98%
Return on Common Equity (ROCE)	18.87%	16.27%	21.32%	22.23%	18.90%	22.26%	26.44%	27.21%	24.72%	10.40%	32.18%
Return on Equity Simple (ROE_SIMPLE)	13.88%	0.00%	14.40%	15.84%	16.27%	0.00%	16.06%	16.79%	18.41%	0.00%	23.70%
Net Operating Profit after Tax (NOPAT)	100	86	133	107	84	97	146	117	100	43	164
NOPAT Margin	6.79%	6.09%	7.65%	7.77%	6.40%	7.25%	8.11%	8.19%	7.06%	2.95%	8.32%
Net Nonoperating Expense Percent (NNEP)	0.80%	1.34%	0.91%	0.83%	0.81%	1.16%	0.95%	0.98%	0.76%	0.61%	0.68%
Return On Investment Capital (ROIC_SIMPLE)	1.48%	1.40%	-	-	-	1.83%	-	-	-	0.83%	-
Cost of Revenue to Revenue	81.56%	83.06%	83.19%	81.47%	83.03%	83.69%	84.14%	82.47%	83.22%	84.01%	84.38%
SG&A Expenses to Revenue	8.80%	8.77%	6.10%	7.80%	7.63%	7.21%	4.68%	7.16%	7.14%	6.63%	4.91%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.54%	10.26%	7.22%	8.26%	8.49%	6.90%	5.09%	7.44%	7.53%	10.41%	4.48%
Earnings before Interest and Taxes (EBIT)	131	94	167	142	112	126	194	144	131	81	219
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	211	173	235	209	179	194	261	212	197	142	285
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.62	2.79	2.73	2.34	2.71	2.51	2.62	2.72	3.25	3.22	2.66
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.91	0.95	0.97	0.77	0.88	0.79	0.76	0.81	0.91	0.86	0.71
Price to Earnings (P/E)	18.88	20.11	18.96	14.76	16.66	14.56	16.30	16.18	17.65	16.23	11.24
Dividend Yield	1.51%	1.46%	1.43%	1.75%	1.51%	1.62%	1.65%	1.47%	1.26%	1.27%	1.52%
Earnings Yield	5.30%	4.97%	5.28%	6.78%	6.00%	6.87%	6.14%	6.18%	5.67%	6.16%	8.90%
Enterprise Value to Invested Capital (EV/IC)	1.53	1.67	1.65	1.47	1.59	1.61	1.51	1.55	1.74	1.84	1.53
Enterprise Value to Revenue (EV/Rev)	1.62	1.52	1.56	1.39	1.48	1.26	1.40	1.44	1.48	1.31	1.27
Enterprise Value to EBITDA (EV/EBITDA)	11.75	11.14	11.06	9.66	10.31	8.71	10.60	10.81	11.13	9.62	8.85
Enterprise Value to EBIT (EV/EBIT)	18.23	17.23	16.54	14.20	15.15	12.65	15.56	15.65	16.01	13.91	12.48
Enterprise Value to NOPAT (EV/NOPAT)	22.98	21.72	21.40	18.73	19.64	16.38	20.94	21.11	22.26	19.35	16.39
Enterprise Value to Operating Cash Flow (EV/OCF)	16.60	12.29	10.46	10.61	15.40	15.60	31.74	31.22	24.59	11.19	18.21
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	14.72	12.12	21.38	21.85	748.89	96.37	26.80	13.97	15.62
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.22	2.08	1.85	2.03	2.04	1.81	2.36	2.22	2.33	1.99	2.27
Long-Term Debt to Equity	1.67	1.72	1.24	1.31	1.33	1.35	1.86	1.79	1.89	1.95	1.92
Financial Leverage	1.97	1.57	1.91	1.98	1.96	1.56	2.16	2.22	2.16	1.83	2.37
Leverage Ratio	4.10	4.18	4.06	4.10	4.19	4.15	4.41	4.52	4.55	4.61	4.78
Compound Leverage Factor	2.75	2.16	3.04	2.91	2.74	2.75	3.34	3.05	3.28	2.64	4.05
Debt to Total Capital	68.96%	67.52%	64.96%	67.02%	67.13%	64.46%	70.26%	68.99%	69.99%	66.59%	69.39%
Short-Term Debt to Total Capital	17.06%	11.70%	21.40%	23.85%	23.28%	16.56%	14.98%	13.45%	13.22%	1.56%	10.69%
Long-Term Debt to Total Capital	51.90%	55.82%	43.56%	43.17%	43.85%	47.90%	55.28%	55.54%	56.77%	65.04%	58.70%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	31.04%	32.48%	35.04%	32.98%	32.87%	35.54%	29.74%	31.01%	30.01%	33.41%	30.61%
Debt to EBITDA	5.59	5.19	4.66	4.66	4.59	3.97	5.21	5.00	4.90	3.94	4.19
Net Debt to EBITDA	5.16	4.16	4.21	4.30	4.22	3.22	4.83	4.71	4.31	3.26	3.92
Long-Term Debt to EBITDA	4.21	4.29	3.12	3.00	3.00	2.95	4.10	4.02	3.97	3.84	3.55
Debt to NOPAT	10.93	10.13	9.01	9.03	8.73	7.45	10.29	9.75	9.80	7.92	7.76
Net Debt to NOPAT	10.09	8.11	8.14	8.34	8.04	6.05	9.54	9.20	8.61	6.56	7.27
Long-Term Debt to NOPAT	8.22	8.37	6.04	5.82	5.71	5.54	8.10	7.85	7.95	7.73	6.57
Altman Z-Score	1.82	1.82	2.05	1.91	1.98	1.94	2.01	2.02	2.09	2.18	2.07
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.14	1.12	1.09	1.06	1.04	1.02	1.39	1.44	1.42	1.48	1.39
Quick Ratio	0.60	0.63	0.68	0.57	0.55	0.54	0.84	0.69	0.78	0.86	0.81
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-788	-544	325	345	48	-18	-251	-216	28	209	188
Operating Cash Flow to CapEx	-824.65%	1,414.07%	518.63%	37.52%	-752.87%	2,026.37%	397.28%	-359.73%	-935.98%	1,618.87%	533.80%
Free Cash Flow to Firm to Interest Expense	-18.35	-11.95	7.77	8.34	1.25	-0.42	-5.32	-4.63	0.77	6.05	5.58
Operating Cash Flow to Interest Expense	-15.92	20.54	7.48	0.51	-14.17	25.38	4.56	-3.85	-17.18	25.03	6.95
Operating Cash Flow Less CapEx to Interest Expense	-17.85	19.08	6.03	-0.84	-16.06	24.13	3.42	-4.92	-19.02	23.49	5.65
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.73	0.72	0.74	0.75	0.76	0.80	0.80	0.79	0.82	0.85	0.85
Accounts Receivable Turnover	6.13	9.81	4.62	5.50	6.26	9.52	5.04	6.27	7.14	9.36	5.93
Inventory Turnover	4.91	5.18	5.64	4.30	4.88	5.84	5.76	4.18	5.15	6.84	6.65
Fixed Asset Turnover	2.83	2.76	2.99	3.02	3.04	3.08	3.21	3.24	3.27	3.27	3.32
Accounts Payable Turnover	7.35	4.43	7.20	6.89	7.40	4.87	7.61	6.42	6.81	5.09	7.41
Days Sales Outstanding (DSO)	59.54	37.21	79.08	66.37	58.35	38.32	72.36	58.17	51.11	38.98	61.57
Days Inventory Outstanding (DIO)	74.26	70.43	64.72	84.80	74.81	62.48	63.38	87.22	70.93	53.36	54.86
Days Payable Outstanding (DPO)	49.69	82.43	50.67	52.97	49.31	74.89	47.99	56.84	53.60	71.70	49.29
Cash Conversion Cycle (CCC)	84.11	25.20	93.13	98.20	83.85	25.91	87.74	88.56	68.44	20.63	67.15
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	6,359	5,304	5,494	5,560	5,472	4,673	5,685	5,797	5,435	4,558	5,288
Invested Capital Turnover	1.02	1.17	1.03	1.03	1.08	1.30	1.11	1.11	1.18	1.38	1.21
Increase / (Decrease) in Invested Capital	887	630	-192	-237	36	115	398	333	72	-166	-24
Enterprise Value (EV)	9,735	8,873	9,045	8,146	8,723	7,530	8,567	9,011	9,442	8,372	8,104
Market Capitalization	5,459	5,559	5,606	4,520	5,151	4,746	4,663	5,085	5,788	5,532	4,509
Book Value per Share	$19.51	$18.63	$19.24	$18.11	$17.84	$17.74	$16.21	$16.97	$16.18	$15.61	$15.36
Tangible Book Value per Share	($11.05)	($11.20)	($6.10)	($6.92)	($7.51)	($7.98)	($8.39)	($8.00)	($8.87)	($9.36)	($8.89)
Total Capital	6,712	6,126	5,862	5,863	5,780	5,316	5,992	6,034	5,936	5,144	5,531
Total Debt	4,629	4,137	3,808	3,929	3,880	3,427	4,210	4,163	4,155	3,425	3,838
Total Long-Term Debt	3,483	3,420	2,554	2,531	2,535	2,546	3,313	3,351	3,370	3,345	3,247
Net Debt	4,276	3,314	3,440	3,626	3,572	2,784	3,903	3,926	3,654	2,840	3,594
Capital Expenditures (CapEx)	83	66	60	56	73	53	54	50	67	53	44
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,104	169	1,100	1,238	1,124	275	1,337	1,394	1,065	189	998
Debt-free Net Working Capital (DFNWC)	1,457	992	1,468	1,541	1,433	917	1,644	1,630	1,566	775	1,242
Net Working Capital (NWC)	312	275	214	143	87	37	746	819	781	695	651
Net Nonoperating Expense (NNE)	32	41	33	31	29	33	36	38	28	18	25
Net Nonoperating Obligations (NNO)	4,276	3,314	3,440	3,626	3,572	2,784	3,903	3,926	3,654	2,840	3,594
Total Depreciation and Amortization (D&A)	81	79	68	67	68	68	67	68	66	61	65
Debt-free, Cash-free Net Working Capital to Revenue	18.39%	2.89%	19.01%	21.19%	19.09%	4.58%	21.90%	22.22%	16.67%	2.95%	15.61%
Debt-free Net Working Capital to Revenue	24.27%	16.95%	25.38%	26.38%	24.34%	15.32%	26.94%	26.00%	24.51%	12.09%	19.42%
Net Working Capital to Revenue	5.20%	4.70%	3.70%	2.44%	1.48%	0.62%	12.23%	13.06%	12.22%	10.84%	10.18%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.64	$0.42	$0.94	$0.71	$0.52	$0.61	$1.02	$0.72	$0.65	$0.22	$1.26
Adjusted Weighted Average Basic Shares Outstanding	106.92M	106.79M	106.85M	106.84M	106.65M	106.50M	108.42M	110.13M	110.22M	110.08M	110.28M
Adjusted Diluted Earnings per Share	$0.63	$0.42	$0.93	$0.71	$0.52	$0.60	$1.02	$0.71	$0.65	$0.23	$1.25
Adjusted Weighted Average Diluted Shares Outstanding	107.34M	106.79M	107.14M	107.02M	107.05M	106.50M	108.75M	110.45M	110.85M	110.08M	110.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	106.99M	106.79M	106.79M	106.78M	106.78M	106.50M	106.50M	109.95M	110.25M	110.08M	110.08M
Normalized Net Operating Profit after Tax (NOPAT)	108	105	149	112	93	94	152	120	104	72	158
Normalized NOPAT Margin	7.35%	7.44%	8.54%	8.13%	7.05%	7.01%	8.42%	8.42%	7.35%	4.94%	8.00%
Pre Tax Income Margin	5.97%	3.45%	7.19%	7.28%	5.55%	6.24%	8.14%	6.81%	6.66%	3.20%	9.42%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.04	2.07	4.00	3.43	2.89	2.97	4.11	3.08	3.57	2.35	6.50
NOPAT to Interest Expense	2.32	1.89	3.19	2.60	2.18	2.29	3.09	2.50	2.72	1.24	4.86
EBIT Less CapEx to Interest Expense	1.11	0.62	2.55	2.08	1.01	1.72	2.96	2.01	1.73	0.80	5.20
NOPAT Less CapEx to Interest Expense	0.39	0.43	1.75	1.25	0.30	1.03	1.95	1.43	0.89	-0.31	3.56
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	28.65%	29.69%	27.37%	26.09%	25.71%	24.20%	27.03%	24.09%	22.50%	21.11%	17.39%
Augmented Payout Ratio	31.60%	33.06%	30.00%	78.57%	83.38%	80.65%	93.31%	35.77%	36.85%	34.35%	27.21%

Frequently Asked Questions About Silgan's Financials

When does Silgan's financial year end?

According to the most recent income statement we have on file, Silgan's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Silgan's net income changed over the last 9 years?

Silgan's net income appears to be on an upward trend, with a most recent value of $276.38 million in 2024, rising from $172.41 million in 2015. The previous period was $325.97 million in 2023. Check out Silgan's forecast to explore projected trends and price targets.

What is Silgan's operating income?

Silgan's total operating income in 2024 was $515.10 million, based on the following breakdown:

Total Gross Profit: $1.01 billion
Total Operating Expenses: $496.68 million

How has Silgan revenue changed over the last 9 years?

Over the last 9 years, Silgan's total revenue changed from $3.76 billion in 2015 to $5.85 billion in 2024, a change of 55.5%.

How much debt does Silgan have?

Silgan's total liabilities were at $6.60 billion at the end of 2024, a 15.3% increase from 2023, and a 158.3% increase since 2015.

How much cash does Silgan have?

In the past 9 years, Silgan's cash and equivalents has ranged from $24.69 million in 2016 to $822.85 million in 2024, and is currently $822.85 million as of their latest financial filing in 2024.

How has Silgan's book value per share changed over the last 9 years?

Over the last 9 years, Silgan's book value per share changed from 10.58 in 2015 to 18.63 in 2024, a change of 76.0%.

Related Companies

This page (NYSE:SLGN) was last updated on 5/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Silgan (SLGN) Financials

Frequently Asked Questions About Silgan's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Silgan (SLGN) Financials

Annual Income Statements for Silgan

Quarterly Income Statements for Silgan

Annual Cash Flow Statements for Silgan

Quarterly Cash Flow Statements for Silgan

Annual Balance Sheets for Silgan

Quarterly Balance Sheets for Silgan

Annual Metrics And Ratios for Silgan

Quarterly Metrics And Ratios for Silgan

Frequently Asked Questions About Silgan's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools